- Home
- Products
- Customized FluoroAb™
- ERBB3
- Patritumab-PBlue
Patritumab-PBlue (CAT#: ADC-FL-1404)
- TARGET
- ANTIBODY
- DYE
- Name
- ERBB3
- Alternative Names
- ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian); LCCS2, lethal congenital contracture syndrome 2; receptor tyrosine-protein kinase erbB-3; HER3; proto-oncogene-like protein c-ErbB-3; tyrosine kinase-type cell surface receptor HER3; LCCS2; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3; MGC88033;
- Overview
- This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.
- Overview
- Human Anti-ERBB3 IgG1-kappa antibody, Patritumab
- Generic name
- Patritumab
- Species Reactivity
- Human
- Name
- Pacific blue
- Color
- Blue
- Excitation⁄Emission (nm)
- 410/455
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-1404. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2367 | Anti-ERBB3 (Duligotuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2241 | Anti-ERBB3 (Duligotumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2370 | Anti-ERBB3 (Duligotuzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-2244 | Anti-ERBB3 (Duligotumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1127 | Anti-ERBB3 (Seribantumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ITGA4 MAb (Clone 5)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2184)
- Anti-EGFR MAb (Clone 2)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS10970)
- Anti-TNFRSF17 MAb (Clone 12)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6533)
- Anti-EGFR MAb (Clone 20)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6998)
- Anti-IL22 MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12930)
- Anti-CD4 MAb (Clone 17)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11916)
- Anti-FGFR2 MAb (Clone 16)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15905)
- Anti-MET MAb (Clone 14)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9097)
- Anti-FGFR2 MAb (Clone 13)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS7953)
- Anti-IL6R MAb (Clone 4)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16739)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
